Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian Sha

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Infection and Immunity|March 11, 2015
High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infectionDuraisamy Ponnusamy, Eric C Fitts, Jian Sha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
T6SS and ExoA of flesh-eating <i>Aeromonas hydrophila</i> in peritonitis and necrotizing fasciitis during mono- and polymicrobial infectionsAna Fernández-Bravo, Paul B Kilgore, Jourdan A Andersson, et al.
Mbio|March 12, 2020
New Host-Directed Therapeutics for the Treatment of Clostridioides difficile InfectionJourdan A Andersson, Alex G Peniche, Cristi L Galindo, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacinJason A Rosenzweig, Sheri M Brackman, Michelle L Kirtley, et al.
Clinical and Vaccine Immunology : CVI|October 9, 2015
Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic PlagueBethany L Tiner, Jian Sha, Duraisamy Ponnusamy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2024
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal CasesRoberto Pineda-Reyes, Blake H Neil, Joseph Orndorff, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2026
Protective mechanism of action of the antifungal drug naftifine against <i>Mycobacterium abscessus</i> infectionJia Wang, Ruchi Paroha, Jian Sha, et al.
Frontiers in Cellular and Infection Microbiology|November 29, 2016
Protective Immunity Elicited by Oral Immunization of Mice with <i>Salmonella enterica</i> Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) MutantsTatiana E Erova, Michelle L Kirtley, Eric C Fitts, et al.
Microbial Pathogenesis|October 16, 2012
A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plagueJian Sha, Jason A Rosenzweig, Michelle L Kirtley, et al.
Microbiology (Reading, England)|July 5, 2008
Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92Stacy L Agar, Jian Sha, Sheri M Foltz, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Infection and Immunity|March 11, 2015
High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infectionDuraisamy Ponnusamy, Eric C Fitts, Jian Sha, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2019
T6SS and ExoA of flesh-eating <i>Aeromonas hydrophila</i> in peritonitis and necrotizing fasciitis during mono- and polymicrobial infectionsAna Fernández-Bravo, Paul B Kilgore, Jourdan A Andersson, et al.
Mbio|March 12, 2020
New Host-Directed Therapeutics for the Treatment of Clostridioides difficile InfectionJourdan A Andersson, Alex G Peniche, Cristi L Galindo, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacinJason A Rosenzweig, Sheri M Brackman, Michelle L Kirtley, et al.
Clinical and Vaccine Immunology : CVI|October 9, 2015
Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic PlagueBethany L Tiner, Jian Sha, Duraisamy Ponnusamy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2024
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal CasesRoberto Pineda-Reyes, Blake H Neil, Joseph Orndorff, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2026
Protective mechanism of action of the antifungal drug naftifine against <i>Mycobacterium abscessus</i> infectionJia Wang, Ruchi Paroha, Jian Sha, et al.
Frontiers in Cellular and Infection Microbiology|November 29, 2016
Protective Immunity Elicited by Oral Immunization of Mice with <i>Salmonella enterica</i> Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) MutantsTatiana E Erova, Michelle L Kirtley, Eric C Fitts, et al.
Microbial Pathogenesis|October 16, 2012
A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plagueJian Sha, Jason A Rosenzweig, Michelle L Kirtley, et al.
Microbiology (Reading, England)|July 5, 2008
Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92Stacy L Agar, Jian Sha, Sheri M Foltz, et al.
Pageof 13